Related Experiment Video
Updated: Apr 1, 2026
10:22
High Speed Droplet-based Delivery System for Passive Pumping in Microfluidic Devices
Published on: September 2, 2009
14.3K
Preface to Special Topic: Microfluidics in Drug Delivery
1Interdisciplinary Nanoscience Center (iNANO), Aarhus University , Aarhus, Denmark.
Biomicrofluidics
|October 1, 2015
Summary
Microfluidics significantly advances drug delivery by optimizing cell-drug interactions and developing novel delivery devices. This synergy enhances biomedical applications for improved patient outcomes.
Area of Science:
- Biomicrofluidics
- Drug Delivery Systems
- Biomedical Engineering
Background:
- Microfluidics offers precise control over biological processes at the microscale.
- Drug delivery faces challenges in targeted delivery, efficacy, and minimizing side effects.
- Integrating microfluidics into drug delivery can overcome existing limitations.
Purpose of the Study:
- To highlight the critical role of microfluidics in advancing drug delivery technologies.
- To explore the synergistic relationship between microfluidics and drug delivery research.
- To showcase innovations in microfluidic devices for enhanced therapeutic applications.
Main Methods:
- Review of current literature on microfluidics in drug delivery.
- Analysis of studies focusing on cell-drug carrier interactions.
- Examination of novel microfluidic device designs for drug delivery.
Main Results:
- Microfluidics enables precise manipulation of drug carriers and cells.
- Development of advanced microfluidic platforms for controlled drug release.
- Demonstration of improved therapeutic efficacy through microfluidic integration.
Conclusions:
- Microfluidics is a transformative technology for next-generation drug delivery.
- The interdisciplinary approach between microfluidics and drug delivery yields significant biomedical advancements.
- Future research will continue to leverage microfluidics for targeted and efficient therapies.
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
111
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
111
01:16Drug Delivery: Overview
1.1K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.1K
01:27Drug Delivery Systems: Different Types
247
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
247
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
109
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
109
01:19Modified-Release Drug Delivery Systems: Overview
176
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
176
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
118
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
118